
Cresco Labs Inc. owns 1 brand in our database. Browse the complete portfolio of Cresco Labs Inc. subsidiaries and brands across various industries.
Company Type
public
Headquarters
Chicago, Illinois, USA
Brand Portfolio
1 brands
Stock
Canadian Securities Exchange: CL
Yes. Cresco Labs trades on the Canadian Securities Exchange under ticker CL, on OTCQX under CRLBF, and on the Frankfurt exchange under 6CQ. Federal prohibition prevents listing on U.S. exchanges like the NYSE or NASDAQ.
Charlie Bachtell, Joe Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack founded the company in 2013 in Chicago, Illinois, coinciding with Illinois' medical cannabis program.
Cresco Labs is a widely held public company with shares distributed among public investors. Co-founder and CEO Charlie Bachtell and early investors hold meaningful insider positions.
Fiscal 2025 revenue was $655.85 million, down 9.5 percent year over year. Trailing twelve-month revenue through Q3 2026 reached $659 million, with Q3 revenue of $173 million up 5 percent.
Cresco Labs Inc. is headquartered in Chicago, Illinois, USA, with operations across eight states where it holds cannabis licenses.
The portfolio includes Cresco, Sunnyside dispensaries, High Supply, FloraCal, Remedi, Good News, Mindy's edibles, and Wonder Wellness Co.
No competing brands found in the same categories. This could be because Cresco Labs Inc.operates in unique market segments or we're still building our competitor database.
Cresco Labs Inc. maintains a diverse portfolio of 1 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Cresco Labs Inc.provides valuable insights into market dynamics, product relationships, and corporate strategy.